Engineering a “muco‐trapping” ACE2 ‐immunoglobulin hybrid with picomolar affinity as an inhaled, pan‐variant immunotherapy for COVID ‐19 is a research paper published in Bioengineering & Translational Medicine (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Science Foundation
Grant: DMS‐2028758
North Carolina Policy Collaboratory
Grant: SLFRP0129
David and Lucile Packard Foundation
Grant: 2013‐39274
National Institutes of Health
Grant: R43AI149894‐01A1
National Institutes of Health
Grant: UL1TR002489
NCATS NIH HHS
Grant: UM1 TR004406
National Institutes of Health
Grant: 1R43AI149894-01A1
Aerosol immunotherapy for treatment of human metapneumovirus infection
National Institutes of Health
Grant: 3UL1TR002489-02S1
North Carolina Translational and Clinical Science Institute (NC TraCS)
National Science Foundation
Grant: 1903010
Rapid: Impact of Hurricane Florence on Drinking Water Safety in Eastern and Central North Carolina: Rapid Assessment and Recommendations for Recovery and Resilience
National Science Foundation
Grant: 2028758
RAPID: A Lung Mucus Strategy for COVID-19 Viral Protection
National Center for Advancing Translational Sciences
FWCI
1.53
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals